IGS GeboJagema is a toolmaker with 120 Fte, located in Eindhoven, the Netherlands. 99% of our turnover is export (of which 40% to US).

Our focus is high-precison moulds needed for injection moulded ultra precision components used in:

  • Medical drug delivery devices: medical closures (Luer Lock), medical packaging and medical consumables (such as contact lens)
  • Biotech consumables: cartridges, cassettes, cuvettes-tubes, strip lid and well plates

Many pharma and diagnostic biotech companies have approved IGS as their preferred toolmaking partner and involve IGS in their projects.

Because we want to meet a “first time right delivery”, we have 8 injection moulding machines on site, and extra space for 12 customer injection moulding machines for a turn-key set up/delivery.

Clients characterize IGS as:

  • Open and transparent in all our communication
  • A partner with added value towards innovative product design input to reduce TCO of the tooling costs
  • Delivery of full validated moulds, including moulding process parameters, resulting in the delivery of moulds that "work out-of-the-box"
  • Partner with engineering, manufacturing and validation power, to run several moulds (6 to 12) at the same time for one device/project.

IGS invites you to challenge our Team and involve in your new product/device and send us your NDA/mould RFQ

IGS GeboJagema
ESP 430
Eindhoven 5633 AJ
Netherlands

Phone+31 40 2647500
Websitewww.igsgebojagema.nl
Emailjw.denhollander@igsgebojagema.nl

LinkedIn logoYouTube logo

Products and Services

Sample Project Tooling Animation

This video animation shows IGS GeboJagema power in handling projects. We have the capacity and track record to handle 11 moulds for 11 components that belong to one drug delivery device including actuator, dustcap and dose counter mechanism More Info

IGS GeboJagema - Company Movie

This video gives you a full overview about IGS GeboJagema in Eindhoven More Info

IGS Smart Solutions to Reduce Carbon Footprint

From Apple and Microsoft to IKEA and Unilever, the largest companies in the world have committed to becoming carbon neutral by 2030. The healthcare industry is no exception; all major players have made plans to make their operations planet-friendly. Those ambitions will have a large effect on the rest of the market too, as suppliers will be required to meet sustainability standards more and more often. IGS GeboJagema has been carbon neutral since 2019. Nonetheless, the company feels it still has plenty of work to do. More Info

Lessons Learned from Two Decades in the Healthcare Industry

In the early 2000s, we delivered our first order for a client in the healthcare industry. Today, the vast majority of our moulds are for medical devices. And despite the global pandemic, we are on course for record-breaking revenue this year. More Info

Major Investments in Four Key Areas for Higher Quality and Improved Lead Times

Last year we laid the groundwork with the largest investment our company has ever made, in robotized machinery, software, new people, training, and an entirely new department. We know that quality and lead times are both of great importance to our customers. So our goal with these investments is to improve quality, to make lead times more reliable and to shorten them where possible. To serve our clients even better in 2021, we invested in four key areas. More Info

Green Moulds – Enabling Sustainable Injection Moulding

By its nature, injection moulding is an energy-intensive process. Moulds are also typically used 24/7, 365 days a year. This means a mould manufacturer can make a large impact by delivering more energy efficient injection moulds. That thought inspired our team to initiate an in-depth investigation into sustainable injection moulding. The objective: to discover whether energy consumption could be reduced by 20%, while retaining product quality and cycle time. More Info

↑ Back to Top